Medindia LOGIN REGISTER
Medindia

Fenofibric Acid Interaction with other Drugs


Fenofibric Acid is used to reduce the cholesterol in patients with obesity problem.

Fenofibric Acid Interaction with 127 drugs. Find out more in the list below:

Acenocoumarol


Fenofibrate may increase the anticoagulant activities of Acenocoumarol.

Acetohexamide


Fenofibrate may increase the hypoglycemic activities of Acetohexamide.

Acipimox


Acipimox may increase the myopathic rhabdomyolysis activities of Fenofibrate.

Advertisement

Amiodarone


The metabolism of Fenofibrate can be decreased when combined with Amiodarone.

Amodiaquine


The serum concentration of Amodiaquine can be increased when it is combined with Fenofibrate.

Anhydrous Tacrolimus


Tacrolimus may increase the nephrotoxic activities of Fenofibrate.

Advertisement

Apalutamide


The serum concentration of Fenofibrate can be decreased when it is combined with Apalutamide.

Aprepitant


The serum concentration of Fenofibrate can be increased when it is combined with Aprepitant.

Atazanavir


The metabolism of Fenofibrate can be decreased when combined with Atazanavir.

Advertisement

Atomoxetine


The metabolism of Fenofibrate can be decreased when combined with Atomoxetine.

Atorvastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.

Boceprevir


The metabolism of Fenofibrate can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Fenofibrate can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Fenofibrate can be decreased when it is combined with Bosentan.

Carbamazepine


The metabolism of Fenofibrate can be increased when combined with Carbamazepine.

Ceritinib


The serum concentration of Fenofibrate can be increased when it is combined with Ceritinib.

Cerivastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Cerivastatin.

Chenodeoxycholate


The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Fenofibrate.

Chenodeoxycholic Acid


The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Fenofibrate.

Chlorpropamide


Fenofibrate may increase the hypoglycemic activities of Chlorpropamide.

Cholestyramine Resin


Cholestyramine can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Ciprofibrate


The risk or severity of adverse effects can be increased when Fenofibrate is combined with Ciprofibrate.

Clarithromycin


The metabolism of Fenofibrate can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Fenofibrate can be decreased when combined with Clemastine.

Clotrimazole


The metabolism of Fenofibrate can be decreased when combined with Clotrimazole.

Cobicistat


The metabolism of Fenofibrate can be decreased when combined with Cobicistat.

Colchicine


Fenofibrate may increase the myopathic rhabdomyolysis activities of Colchicine.

Colesevelam


Colesevelam can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Colestipol


Colestipol can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Fenofibrate.

Crizotinib


The metabolism of Fenofibrate can be decreased when combined with Crizotinib.

Cyclosporine


Cyclosporine may increase the nephrotoxic activities of Fenofibrate.

Dabrafenib


The serum concentration of Fenofibrate can be decreased when it is combined with Dabrafenib.

Darunavir


The metabolism of Fenofibrate can be decreased when combined with Darunavir.

Dasatinib


The serum concentration of Fenofibrate can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Fenofibrate can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Fenofibrate can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Fenofibrate can be decreased when combined with Delavirdine.

Dicumarol


Fenofibrate may increase the anticoagulant activities of Dicoumarol.

Dihydroergotamine


The metabolism of Fenofibrate can be decreased when combined with Dihydroergotamine.

Diltiazem


The metabolism of Fenofibrate can be decreased when combined with Diltiazem.

Doxycycline


The metabolism of Fenofibrate can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Fenofibrate can be decreased when combined with Doxycycline.

Dronedarone


The metabolism of Fenofibrate can be decreased when combined with Dronedarone.

Enzalutamide


The serum concentration of Fenofibrate can be decreased when it is combined with Enzalutamide.

Erythromycin


The metabolism of Fenofibrate can be decreased when combined with Erythromycin.

Ezetimibe


The risk or severity of adverse effects can be increased when Fenofibrate is combined with Ezetimibe.

Fluconazole


The metabolism of Fenofibrate can be decreased when combined with Fluconazole.

Fluindione


Fenofibrate may increase the anticoagulant activities of Fluindione.

Fluvastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.

Fluvoxamine


The metabolism of Fenofibrate can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Fenofibrate can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Fenofibrate can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The metabolism of Fenofibrate can be increased when combined with Fosphenytoin.

Fusidate


The serum concentration of Fenofibrate can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Fenofibrate can be increased when it is combined with Fusidic Acid.

Glibornuride


Fenofibrate may increase the hypoglycemic activities of Glibornuride.

Gliclazide


Fenofibrate may increase the hypoglycemic activities of Gliclazide.

Glimepiride


Fenofibrate may increase the hypoglycemic activities of Glimepiride.

Glipizide


Fenofibrate may increase the hypoglycemic activities of Glipizide.

Gliquidone


Fenofibrate may increase the hypoglycemic activities of Gliquidone.

Glyburide


Fenofibrate may increase the hypoglycemic activities of Glyburide.

Hypoxis hemerocallidea root extract


The serum concentration of Fenofibrate can be decreased when it is combined with St. John's Wort.

Idelalisib


The metabolism of Fenofibrate can be decreased when combined with Idelalisib.

Imatinib


The metabolism of Fenofibrate can be decreased when combined with Imatinib.

Indinavir


The metabolism of Fenofibrate can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Fenofibrate can be decreased when combined with Indinavir.

Isavuconazole


The serum concentration of Fenofibrate can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Fenofibrate can be decreased when combined with Isavuconazonium.

Isradipine


The metabolism of Fenofibrate can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Fenofibrate can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Fenofibrate can be increased when it is combined with Ivacaftor.

Ketoconazole


The metabolism of Fenofibrate can be decreased when combined with Ketoconazole.

Lopinavir


The metabolism of Fenofibrate can be decreased when combined with Lopinavir.

Lovastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.

Luliconazole


The serum concentration of Fenofibrate can be increased when it is combined with Luliconazole.

Lumacaftor


The metabolism of Fenofibrate can be increased when combined with Lumacaftor.

Mifepristone


The serum concentration of Fenofibrate can be increased when it is combined with Mifepristone.

Mitotane


The serum concentration of Fenofibrate can be decreased when it is combined with Mitotane.

Nefazodone


The metabolism of Fenofibrate can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Fenofibrate can be decreased when combined with Nelfinavir.

Netupitant


The serum concentration of Fenofibrate can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Fenofibrate can be increased when combined with Nevirapine.

Nilotinib


The metabolism of Fenofibrate can be decreased when combined with Nilotinib.

Olaparib


The metabolism of Fenofibrate can be decreased when combined with Olaparib.

Osimertinib


The serum concentration of Fenofibrate can be increased when it is combined with Osimertinib.

Palbociclib


The serum concentration of Fenofibrate can be increased when it is combined with Palbociclib.

Pentobarbital


The metabolism of Fenofibrate can be increased when combined with Pentobarbital.

Phenindione


Fenofibrate may increase the anticoagulant activities of Phenindione.

Phenobarbital


The metabolism of Fenofibrate can be increased when combined with Phenobarbital.

Phenprocoumon


Fenofibrate may increase the anticoagulant activities of Phenprocoumon.

Phenytoin


The metabolism of Fenofibrate can be increased when combined with Phenytoin.

Pitavastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pitavastatin.

Posaconazole


The metabolism of Fenofibrate can be decreased when combined with Posaconazole.

Pravastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.

Primidone


The metabolism of Fenofibrate can be increased when combined with Primidone.

Raltegravir


Raltegravir may increase the myopathic rhabdomyolysis activities of Fenofibrate.

Ranolazine


The metabolism of Fenofibrate can be decreased when combined with Ranolazine.

Rifabutin


The metabolism of Fenofibrate can be increased when combined with Rifabutin.

Rifampin


The metabolism of Fenofibrate can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Fenofibrate can be increased when combined with Rifapentine.

Rosuvastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.

Rucaparib


The metabolism of Fenofibrate can be decreased when combined with Rucaparib.

Saquinavir


The metabolism of Fenofibrate can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Fenofibrate can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Fenofibrate can be decreased when used in combination with Sarilumab.

Sildenafil


The metabolism of Fenofibrate can be decreased when combined with Sildenafil.

Siltuximab


The serum concentration of Fenofibrate can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Fenofibrate can be increased when it is combined with Simeprevir.

Simvastatin


The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.

ST. JOHN'S WORT EXTRACT


The serum concentration of Fenofibrate can be decreased when it is combined with St. John's Wort.

Sulfisoxazole


The metabolism of Fenofibrate can be decreased when combined with Sulfisoxazole.

Tacrolimus


Tacrolimus may increase the nephrotoxic activities of Fenofibrate.

Telaprevir


The metabolism of Fenofibrate can be decreased when combined with Telaprevir.

Telithromycin


The metabolism of Fenofibrate can be decreased when combined with Telithromycin.

Ticlopidine


The metabolism of Fenofibrate can be decreased when combined with Ticlopidine.

Tocilizumab


The serum concentration of Fenofibrate can be decreased when it is combined with Tocilizumab.

Tolazamide


Fenofibrate may increase the hypoglycemic activities of Tolazamide.

Tolbutamide


Fenofibrate may increase the hypoglycemic activities of Tolbutamide.

Ursodeoxycholate


The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.

Ursodiol


The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.

Vemurafenib


The serum concentration of Fenofibrate can be decreased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Fenofibrate can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Fenofibrate can be decreased when combined with Verapamil.

Voriconazole


The metabolism of Fenofibrate can be decreased when combined with Voriconazole.

Warfarin


Fenofibrate may increase the anticoagulant activities of Warfarin.

Ziprasidone


The metabolism of Fenofibrate can be decreased when combined with Ziprasidone.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ultimate Weight Loss Handbook: A Complete Guide to Achieving Your Goals
Stay Connected
Available on the Android Market Available on the App Store